The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

计划入组 17 人 · 首次发布于 2017 年 9 月 27 日

Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124

首次发布于 2017 年 3 月 23 日

The SHUNT-V Study for Varices

计划入组 306 人 · 首次发布于 2018 年 7 月 12 日

Diagnostic Patch for Allergic Contact Dermatitis

Rx

test Sequence

Diagnostic T320

HepQuant, LLC

United States

Heart Test Laboratories

United States

LIVER INSTITUTE PLLC

United States

FDA Grants Premarket Approval to HepQuant SHUNT Liver Diagnostic Test for Compensated Cirrhosis

Linear Diagnostics Secures £1M to Advance 5-Minute STI Diagnostic Test

Breakthrough Diagnostic Tools for Early Fatty Liver Disease Detection: AI and Blood Tests Show Promise